Eli Lilly | LLY - 债务



金融业
股票价格
USD 1,417.99
资产
USD 148.07B
现金及等价物
USD 4.89B
销售成本
USD 3.93B
流动资产
USD 65.26B
流动负债
USD 47B
债务
USD 54.91B
股息收益率
0.58
EBIT
USD 13.09B
EBITDA
USD 9.46B
员工
47K
EPS每股收益
USD 7.48
股本和储备
USD 40.27B
销售毛利
USD 20.59B
债务利息支出
USD 316M
利息收入
USD 65M
贷款资金
USD 46.99B
市值
USD 1350.42B
净收入
USD 7.1B
营业费用
USD 10.52B
营业利润
USD 12.46B
普通股股本
USD 943.5M
PE价格收益
64.5
税前利润
USD 8.79B
销售收入
USD 24.4B
销售和管理费用
USD 3.13B
股票
USD 18.19B
贸易债权人
USD 5.79B
应收帐款人
USD 23.48B


债务 更改 日
AbbVie USD 70.82B 2.04B 2026-06
Abbott USD 34.05B 20.19B 2026-03
ALKERMES USD 1.58B 1.51B 2026-03
Amgen USD 57.3B 19M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Baxter International USD 9.67B 20M 2026-06
Biogen USD 7.69B 398.3M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Drreddys Laboratories INR 72.29B 5.05B 2026-09
Eli Lilly USD 54.91B 11.54B 2026-06
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Glaxosmithkline GBP 23.7B 4.65B 2026-09
J&J USD 49.04B 5.95B 2026-06
Medtronic USD 28.15B 192M 2026-06
Merck USD 53.91B 4.79B 2026-06
Neurocrine Biosciences USD 401.8M 4.4M 2026-06
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 48.31B 1.31B 2026-09
Novo Nordisk DKK 118.72B 61.75B 2025-03
Perrigo USD 3.29B 337.7M 2026-06
Pfizer USD 63.19B 536M 2026-06
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.05B 33.86M 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Sanofi EUR 23.58B 3.56B 2026-06
United Therapeutics USD 200M 100M 2025-03
Zoetis USD 9.24B 0 2026-03